The Dow moved beyond a psychological threshold, building on the market optimism seen this week
The blue-chip index, up 0.6%, was heading for its second consecutive gain this week. If it closes at its current 268 point gain, it’ll be the largest point gain since Jan. 27.
The Dow was riding higher on gains in Amgen’s stock. The biotech is responsible for a 109-point increase in the index. Goldman Sachs and Sherwin-Williams shares closely followed, contributing 59 and 46 points, respectively. The Dow is price-weighted, which means stocks with higher prices have a greater influence.